Detail Information of Microbiota Influence

General Information of Drug Transporter (DT)
DT ID	DTD0342 Transporter Info
Gene Name	SLC39A14
Transporter Name	Zinc transporter ZIP14
Gene ID	23516
UniProt ID	Q15043

Microbiota Influence of This DT (MBI)

Bacteria: Actinomycetota
Genus: Corynebacterium
Corynebacterium diphtheriae	Microbe Info	Click to Show/Hide the Full List 1 Microbe Influence Related to This Species
Microbe Influence1	Sequestration of human SLC39A14 substrates/drugs in the health condition		[1], [2], [3], [4]
Regulating Factor	Corynebactin
Detailed Description	The compound Corynebactin Secreted by Corynebacterium diphtheriae C7 (beta) has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Genus: Mycobacterium
Mycobacterium avium	Microbe Info	Click to Show/Hide the Full List 1 Microbe Influence Related to This Species
Microbe Influence1	Sequestration of human SLC39A14 substrates/drugs in the health condition		[5], [3], [4]
Regulating Factor	Carboxymycobactin
Detailed Description	The compound Carboxymycobactin Secreted by Mycobacterium avium CRl/69 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Mycobacterium tuberculosis	Microbe Info	Click to Show/Hide the Full List 8 Microbe Influence Related to This Species
Microbe Influence1	Sequestration of human SLC39A14 substrates/drugs in the health condition		[3], [4], [6], [7]
Regulating Factor	Desferriexochelin 772MS
Detailed Description	The compound Desferriexochelin 772MS Secreted by Mycobacterium tuberculosis str. Erdman has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence2	Sequestration of human SLC39A14 substrates/drugs in the health condition		[6], [3], [4]
Regulating Factor	desA1
Detailed Description	The protein desA1 of Mycobacterium tuberculosis H37Ra has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence3	Sequestration of human SLC39A14 substrates/drugs in the health condition		[6], [3], [4]
Regulating Factor	GAPDH
Detailed Description	The protein GAPDH of Mycobacterium tuberculosis H37Ra has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence4	Co-transport of human SLC39A14 substrates/drugs in the health condition		[6], [8], [4]
Regulating Factor	IrtAB ,
Detailed Description	The protein IrtAB of Mycobacterium tuberculosis H37Rv has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.
Microbe Influence5	Sequestration of human SLC39A14 substrates/drugs in the health condition		[6], [3], [4]
Regulating Factor	Rv0641
Detailed Description	The protein Rv0641 of Mycobacterium tuberculosis H37Ra has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence6	Sequestration of human SLC39A14 substrates/drugs in the health condition		[6], [3], [4]
Regulating Factor	Rv0704
Detailed Description	The protein Rv0704 of Mycobacterium tuberculosis H37Ra has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence7	Sequestration of human SLC39A14 substrates/drugs in the health condition		[6], [3], [4]
Regulating Factor	Rv1872c
Detailed Description	The protein Rv1872c of Mycobacterium tuberculosis H37Ra has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence8	Sequestration of human SLC39A14 substrates/drugs in the health condition		[6], [3], [4]
Regulating Factor	tuf
Detailed Description	The protein tuf of Mycobacterium tuberculosis H37Ra has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Genus: Mycolicibacterium
Mycolicibacterium vaccae	Microbe Info	Click to Show/Hide the Full List 1 Microbe Influence Related to This Species
Microbe Influence1	Sequestration of human SLC39A14 substrates/drugs in the health condition		[3], [4], [6], [9]
Regulating Factor	Exochelin 772SM
Detailed Description	The compound Exochelin 772SM Secreted by Mycolicibacterium vaccae R877R has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Bacteria: Bacillota
Genus: Bacillus
Bacillus anthracis	Microbe Info	Click to Show/Hide the Full List 3 Microbe Influence Related to This Species
Microbe Influence1	Sequestration of human SLC39A14 substrates/drugs in the health condition		[3], [4], [10], [11], [12]
Regulating Factor	Corynebactin
Detailed Description	The compound Corynebactin Secreted by Bacillus anthracis str. Sterne has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence2	Sequestration of human SLC39A14 substrates/drugs in the health condition		[3], [4], [10], [11], [12]
Regulating Factor	Petrobactin
Detailed Description	The compound Petrobactin Secreted by Bacillus anthracis str. Sterne has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence3	Sequestration of human SLC39A14 substrates/drugs in the health condition		[13], [14], [3], [4]
Regulating Factor	Petrobactin
Detailed Description	The compound Petrobactin Secreted by Bacillus anthracis str. Sterne has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Bacillus cereus	Microbe Info	Click to Show/Hide the Full List 2 Microbe Influence Related to This Species
Microbe Influence1	Sequestration of human SLC39A14 substrates/drugs in the health condition		[3], [4], [10], [11], [12]
Regulating Factor	Corynebactin
Detailed Description	The compound Corynebactin Secreted by Bacillus cereus ATCC 14579 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence2	Sequestration of human SLC39A14 substrates/drugs in the health condition		[3], [4], [10], [11], [12]
Regulating Factor	Petrobactin
Detailed Description	The compound Petrobactin Secreted by Bacillus cereus ATCC 14579 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Bacillus subtilis	Microbe Info	Click to Show/Hide the Full List 2 Microbe Influence Related to This Species
Microbe Influence1	Sequestration of human SLC39A14 substrates/drugs in the health condition		[15], [16], [17], [18]
Regulating Factor	ycdH
Detailed Description	The protein ycdH of Bacillus subtilis ZB307A has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence2	Sequestration of human SLC39A14 substrates/drugs in the health condition		[15], [16], [17], [18]
Regulating Factor	yciC
Detailed Description	The protein yciC of Bacillus subtilis ZB307A has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Bacillus thuringiensis	Microbe Info	Click to Show/Hide the Full List 1 Microbe Influence Related to This Species
Microbe Influence1	Sequestration of human SLC39A14 substrates/drugs in the health condition		[3], [4], [10], [11], [12]
Regulating Factor	Corynebactin
Detailed Description	The compound Corynebactin Secreted by Bacillus thuringiensis ATCC 33679 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Genus: Lactococcus
Lactococcus lactis	Microbe Info	Click to Show/Hide the Full List 1 Microbe Influence Related to This Species
Microbe Influence1	Co-transport of human SLC39A14 substrates/drugs in the health condition		[15], [18], [19], [20]
Regulating Factor	ZitSQP , ,
Detailed Description	The protein ZitSQP of Lactococcus lactis subsp. lactis Il1403 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.
Genus: Listeria
Listeria monocytogenes	Microbe Info	Click to Show/Hide the Full List 2 Microbe Influence Related to This Species
Microbe Influence1	Sequestration of human SLC39A14 substrates/drugs in the health condition		[15], [18], [21]
Regulating Factor	zinA
Studied Tissue	Uterus
In Vivo Model	MF1 mice
In Vitro Model	Human papillomavirus-related endocervical adenocarcinoma cells (HeLa M)
Detailed Description	The protein zinA of Listeria monocytogenes EGD-e has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence2	Co-transport of human SLC39A14 substrates/drugs in the health condition		[15], [18], [21]
Regulating Factor	ZurAM ,
Studied Tissue	Uterus
In Vivo Model	MF1 mice
In Vitro Model	Human papillomavirus-related endocervical adenocarcinoma cells (HeLa M)
Detailed Description	The protein ZurAM of Listeria monocytogenes EGD-e has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.
Genus: Staphylococcus
Staphylococcus aureus	Microbe Info	Click to Show/Hide the Full List 16 Microbe Influence Related to This Species
Microbe Influence1	Sequestration of human SLC39A14 substrates/drugs in the health condition		[5], [22], [3], [4]
Regulating Factor	Aureochelin
Detailed Description	The compound aureochelin secreted by Staphylococcus aureus has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence2	Sequestration of human SLC39A14 substrates/drugs in the health condition		[10], [23], [3], [4]
Regulating Factor	Staphyloferrin A
Detailed Description	The compound Staphyloferrin A Secreted by Staphylococcus aureus subsp. aureus NCTC 8325 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence3	Sequestration of human SLC39A14 substrates/drugs in the health condition		[1], [24], [3], [4]
Regulating Factor	Staphylopine
Detailed Description	The compound Staphylopine Secreted by Staphylococcus aureus RN6390 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence4	Co-transport of human SLC39A14 substrates/drugs in the health condition		[15], [18], [25], [26], [27]
Regulating Factor	CzrA
Detailed Description	The protein czra of Staphylococcus aureus has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.
Microbe Influence5	Co-transport of human SLC39A14 substrates/drugs in the health condition		[28], [29], [4]
Regulating Factor	FhuCBG , ,
Detailed Description	The protein FhuCBG of Staphylococcus aureus RN6390 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.
Microbe Influence6	Sequestration of human SLC39A14 substrates/drugs in the health condition		[28], [29], [4]
Regulating Factor	fhuD1
Detailed Description	The protein fhuD1 of Staphylococcus aureus RN6390 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence7	Sequestration of human SLC39A14 substrates/drugs in the health condition		[28], [29], [4]
Regulating Factor	fhud2
Detailed Description	The protein fhud2 of Staphylococcus aureus RN6390 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence8	Sequestration of human SLC39A14 substrates/drugs in the health condition		[1], [30], [4]
Regulating Factor	fhud2
Detailed Description	The protein fhud2 of Staphylococcus aureus RN2564 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence9	Co-transport of human SLC39A14 substrates/drugs in the health condition		[28], [31], [3], [4]
Regulating Factor	HtsABC , ,
Detailed Description	The protein HtsABC of Staphylococcus aureus RN6390 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.
Microbe Influence10	Sequestration of human SLC39A14 substrates/drugs in the health condition		[6], [32], [3], [4]
Regulating Factor	isdA
Detailed Description	The protein isdA of Staphylococcus aureus RN6390 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence11	Sequestration of human SLC39A14 substrates/drugs in the health condition		[6], [33], [3], [4]
Regulating Factor	isdA
Detailed Description	The protein isdA of Staphylococcus aureus BB has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence12	Sequestration of human SLC39A14 substrates/drugs in the health condition		[10], [34], [3], [4]
Regulating Factor	isdA
Detailed Description	The protein isdA of Staphylococcus aureus N100 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence13	Co-transport of human SLC39A14 substrates/drugs in the health condition		[35], [36], [37], [4]
Regulating Factor	MntABC , ,
Detailed Description	The protein MntABC of Staphylococcus aureus subsp. aureus NCTC 8325 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.
Microbe Influence14	Sequestration of human SLC39A14 substrates/drugs in the health condition		[28], [31], [3], [4]
Regulating Factor	SfaABC , ,
Detailed Description	The protein SfaABC of Staphylococcus aureus RN6390 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence15	Co-transport of human SLC39A14 substrates/drugs in the health condition		[28], [38], [3], [4]
Regulating Factor	SirABC , ,
Detailed Description	The protein SirABC of Staphylococcus aureus subsp. aureus RN4220 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.
Microbe Influence16	Co-transport of human SLC39A14 substrates/drugs in the health condition		[28], [39], [3], [4]
Regulating Factor	SstABCD , , ,
Detailed Description	The protein SstABCD of Staphylococcus aureus W has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.
Staphylococcus epidermidis	Microbe Info	Click to Show/Hide the Full List 2 Microbe Influence Related to This Species
Microbe Influence1	Sequestration of human SLC39A14 substrates/drugs in the health condition		[6], [33], [3], [4]
Regulating Factor	Tpn
Detailed Description	The protein tpn of Staphylococcus epidermidis 138 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence2	Sequestration of human SLC39A14 substrates/drugs in the health condition		[10], [34], [3], [4]
Regulating Factor	Tpn
Detailed Description	The protein tpn of Staphylococcus epidermidis 2 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Genus: Streptococcus
Streptococcus agalactiae	Microbe Info	Click to Show/Hide the Full List 1 Microbe Influence Related to This Species
Microbe Influence1	Co-transport of human SLC39A14 substrates/drugs in the health condition		[10], [40], [4]
Regulating Factor	FhuCDB , ,
Detailed Description	The protein FhuCDB of Streptococcus agalactiae A909 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.
Streptococcus equi	Microbe Info	Click to Show/Hide the Full List 2 Microbe Influence Related to This Species
Microbe Influence1	Sequestration of human SLC39A14 substrates/drugs in upper and lower airway disease condition		[16], [41], [4]
Regulating Factor	mtsB
Studied Phenotype	Upper and lower airway disease [ICD11: CA22]
Studied Tissue	Lung
In Vivo Model	Swiss Webster mice
Detailed Description	The protein mtsB of Streptococcus equi subsp. equi NCTC 9682 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence2	Sequestration of human SLC39A14 substrates/drugs in the health condition		[16], [41], [4]
Regulating Factor	mtsB
Detailed Description	The protein mtsB of Streptococcus equi subsp. zooepidemicus NCTC 7023T has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Streptococcus gordonii	Microbe Info	Click to Show/Hide the Full List 1 Microbe Influence Related to This Species
Microbe Influence1	Co-transport of human SLC39A14 substrates/drugs in the health condition		[15], [18], [35], [36], [42]
Regulating Factor	AdcRCBA , , ,
Detailed Description	The protein AdcRCBA of Streptococcus gordonii str. Challis has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.
Streptococcus pneumoniae	Microbe Info	Click to Show/Hide the Full List 1 Microbe Influence Related to This Species
Microbe Influence1	Co-transport of human SLC39A14 substrates/drugs in the health condition		[15], [18], [43]
Regulating Factor	AdcCBA , ,
Detailed Description	The protein AdcCBA of Streptococcus pneumoniae D39 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.
Streptococcus suis	Microbe Info	Click to Show/Hide the Full List 1 Microbe Influence Related to This Species
Microbe Influence1	Sequestration of human SLC39A14 substrates/drugs in sepsis condition		[35], [44], [4]
Regulating Factor	troA
Studied Phenotype	Sepsis [ICD11: 1G40-1G41]
Studied Tissue	Liver
In Vivo Model	CD-1 mice
Detailed Description	The protein troA of Streptococcus suis serotype 9 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Bacteria: Campylobacterota
Genus: Campylobacter
Campylobacter coli	Microbe Info	Click to Show/Hide the Full List 1 Microbe Influence Related to This Species
Microbe Influence1	Sequestration of human SLC39A14 substrates/drugs in the health condition		[3], [4], [45], [46], [47]
Regulating Factor	cfrB
Detailed Description	The protein cfrB of Campylobacter coli W13A has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Campylobacter jejuni	Microbe Info	Click to Show/Hide the Full List 6 Microbe Influence Related to This Species
Microbe Influence1	Sequestration of human SLC39A14 substrates/drugs in gastroenteritis condition		[15], [48], [49], [18]
Regulating Factor	znuA
Studied Phenotype	Gastroenteritis [ICD11: 1A40]
Studied Tissue	Jejunum
In Vivo Model	Chicken
Detailed Description	The protein znuA of Campylobacter jejuni subsp. jejuni 81-176 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence2	Sequestration of human SLC39A14 substrates/drugs in the health condition		[3], [4], [45], [46], [50]
Regulating Factor	cfrA
Detailed Description	The protein cfrA of Campylobacter jejuni subsp. jejuni NCTC 11168 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence3	Sequestration of human SLC39A14 substrates/drugs in the health condition		[3], [4], [45], [46], [47]
Regulating Factor	cfrB
Detailed Description	The protein cfrB of Campylobacter jejuni subsp. jejuni NCTC 11168 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence4	Sequestration of human SLC39A14 substrates/drugs in the health condition		[3], [4], [45], [46], [51]
Regulating Factor	ctuA
Detailed Description	The protein ctuA of Campylobacter jejuni subsp. jejuni NCTC 11168 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence5	Co-transport of human SLC39A14 substrates/drugs in the health condition		[45], [46], [52], [4]
Regulating Factor	feoB
Detailed Description	The protein feoB of Campylobacter jejuni subsp. jejuni NCTC 11168 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.
Microbe Influence6	Sequestration of human SLC39A14 substrates/drugs in the health condition		[45], [53], [4]
Regulating Factor	p19
Detailed Description	The protein p19 of Campylobacter jejuni subsp. jejuni NCTC 11168 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Bacteria: Cyanobacteriota
Genus: Synechocystis
Synechocystis sp. PCC 6803	Microbe Info	Click to Show/Hide the Full List 4 Microbe Influence Related to This Species
Microbe Influence1	Sequestration of human SLC39A14 substrates/drugs in the health condition		[54], [55], [4]
Regulating Factor	futA1
Detailed Description	The protein futa1 of Synechocystis sp. PCC 6803 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence2	Sequestration of human SLC39A14 substrates/drugs in the health condition		[54], [55], [4]
Regulating Factor	futA2
Detailed Description	The protein futa2 of Synechocystis sp. PCC 6803 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence3	Sequestration of human SLC39A14 substrates/drugs in the health condition		[54], [55], [4]
Regulating Factor	futB
Detailed Description	The protein futb of Synechocystis sp. PCC 6803 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence4	Sequestration of human SLC39A14 substrates/drugs in the health condition		[54], [56], [4]
Regulating Factor	sll1878
Detailed Description	The protein sll1878 of Synechocystis sp. PCC 6803 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Bacteria: Pseudomonadota
Genus: Achromobacter
Achromobacter xylosoxidans	Microbe Info	Click to Show/Hide the Full List 1 Microbe Influence Related to This Species
Microbe Influence1	Sequestration of human SLC39A14 substrates/drugs in the health condition		[5], [3], [4]
Regulating Factor	Alcaligin
Detailed Description	The compound Alcaligin Secreted by Achromobacter xylosoxidans subsp. xylosoxydans KN 3-1 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Genus: Acinetobacter
Acinetobacter baumannii	Microbe Info	Click to Show/Hide the Full List 2 Microbe Influence Related to This Species
Microbe Influence1	Co-transport of human SLC39A14 substrates/drugs in the health condition		[57], [3], [4]
Regulating Factor	tonB3
Detailed Description	The protein tonB3 of Acinetobacter baumannii ATCC 19606 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.
Microbe Influence2	Co-transport of human SLC39A14 substrates/drugs in the health condition		[15], [58], [18]
Regulating Factor	ZnuABC , ,
Detailed Description	The protein ZnuABC of Acinetobacter baumannii ATCC 17978 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.
Genus: Bordetella
Bordetella bronchiseptica	Microbe Info	Click to Show/Hide the Full List 1 Microbe Influence Related to This Species
Microbe Influence1	Sequestration of human SLC39A14 substrates/drugs in the health condition		[5], [59], [3], [4]
Regulating Factor	Alcaligin
Detailed Description	The compound Alcaligin Secreted by Bordetella bronchiseptica B013N has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Bordetella pertussis	Microbe Info	Click to Show/Hide the Full List 1 Microbe Influence Related to This Species
Microbe Influence1	Sequestration of human SLC39A14 substrates/drugs in the health condition		[5], [59], [3], [4]
Regulating Factor	Alcaligin
Detailed Description	The compound Alcaligin Secreted by Bordetella pertussis UT25 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Genus: Bradyrhizobium
Bradyrhizobium diazoefficiens	Microbe Info	Click to Show/Hide the Full List 1 Microbe Influence Related to This Species
Microbe Influence1	Co-transport of human SLC39A14 substrates/drugs in the health condition		[35], [60], [4]
Regulating Factor	mnoP
Detailed Description	The protein mnoP of Bradyrhizobium diazoefficiens USDA 110 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.
Genus: Brucella
Brucella abortus	Microbe Info	Click to Show/Hide the Full List 1 Microbe Influence Related to This Species
Microbe Influence1	Sequestration of human SLC39A14 substrates/drugs in the health condition		[15], [61], [18]
Regulating Factor	znuA
Studied Tissue	Cervix
In Vivo Model	BALB/c athymic Nu/Nu mice
In Vitro Model	Human human papillomavirus-related endocervical adenocarcinoma cells (HeLa)
Detailed Description	The protein znua of Brucella abortus 544 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Genus: Burkholderia
Burkholderia cepacia	Microbe Info	Click to Show/Hide the Full List 3 Microbe Influence Related to This Species
Microbe Influence1	Sequestration of human SLC39A14 substrates/drugs in the health condition		[5], [62], [3], [4]
Regulating Factor	Cepabactin
Detailed Description	The compound Cepabactin Secreted by Burkholderia cepacia ATCC 25416 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence2	Sequestration of human SLC39A14 substrates/drugs in the health condition		[5], [63], [3], [4]
Regulating Factor	Ornibactin
Detailed Description	The compound Ornibactin Secreted by Burkholderia cepacia TVV69 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence3	Sequestration of human SLC39A14 substrates/drugs in the health condition		[5], [64], [3], [4]
Regulating Factor	Salicylic acid
Detailed Description	The compound Salicylic acid Secreted by Burkholderia cepacia Pc275c has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Genus: Escherichia
Escherichia coli	Microbe Info	Click to Show/Hide the Full List 19 Microbe Influence Related to This Species
Microbe Influence1	Sequestration of human SLC39A14 substrates/drugs in the health condition		[5], [65], [3], [4]
Regulating Factor	Aerobactin
Detailed Description	The compound Aerobactin Secreted by Escherichia coli LG1315 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence2	Sequestration of human SLC39A14 substrates/drugs in the health condition		[66], [3], [4]
Regulating Factor	Enterobactin
Detailed Description	The compound Enterobactin Secreted by Escherichia coli BW25113 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence3	Sequestration of human SLC39A14 substrates/drugs in the health condition		[5], [65], [3], [4]
Regulating Factor	Enterobactin
Detailed Description	The compound Enterobactin Secreted by Escherichia coli str. K-12 substr. W3110 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence4	Sequestration of human SLC39A14 substrates/drugs in the health condition		[15], [67], [3], [4]
Regulating Factor	Enterobactin
Detailed Description	The compound enterobactin secreted by Escherichia coli 9.0111 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence5	Sequestration of human SLC39A14 substrates/drugs in the health condition		[15], [68], [3], [4]
Regulating Factor	Enterobactin
Detailed Description	The compound Enterobactin Secreted by Escherichia coli AB33II has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence6	Sequestration of human SLC39A14 substrates/drugs in the health condition		[54], [69], [3], [4]
Regulating Factor	efeO
Detailed Description	The protein efeO of Escherichia coli Nissle 1917 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence7	Co-transport of human SLC39A14 substrates/drugs in the health condition		[54], [70], [4]
Regulating Factor	efeU
Detailed Description	The protein efeU of Escherichia coli O157:H7 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.
Microbe Influence8	Co-transport of human SLC39A14 substrates/drugs in the health condition		[54], [69], [4]
Regulating Factor	efeU
Detailed Description	The protein efeU of Escherichia coli Nissle 1917 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.
Microbe Influence9	Co-transport of human SLC39A14 substrates/drugs in the health condition		[10], [71], [4]
Regulating Factor	fecA
Detailed Description	The protein fecA of Escherichia coli UT5600 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.
Microbe Influence10	Sequestration of human SLC39A14 substrates/drugs in the health condition		[10], [72], [4]
Regulating Factor	feoA
Detailed Description	The protein feoA of Escherichia coli str. K-12 substr. MC4100 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence11	Co-transport of human SLC39A14 substrates/drugs in the health condition		[10], [72], [4]
Regulating Factor	feoB
Detailed Description	The protein feoB of Escherichia coli str. K-12 substr. MC4100 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.
Microbe Influence12	Co-transport of human SLC39A14 substrates/drugs in the health condition		[73], [74], [4]
Regulating Factor	fhuA
Detailed Description	The protein fhuA of Escherichia coli K-12 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.
Microbe Influence13	Co-transport of human SLC39A14 substrates/drugs in the health condition		[73], [75], [4]
Regulating Factor	fhuB
Detailed Description	The protein fhuB of Escherichia coli DH5[alpha] has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.
Microbe Influence14	Co-transport of human SLC39A14 substrates/drugs in the health condition		[73], [76], [4]
Regulating Factor	fhuC
Detailed Description	The protein fhuC of Escherichia coli AB2847 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.
Microbe Influence15	Sequestration of human SLC39A14 substrates/drugs in the health condition		[73], [77], [4]
Regulating Factor	fhuD
Detailed Description	The protein fhuD of Escherichia coli BL21(DE3) has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence16	Co-transport of human SLC39A14 substrates/drugs in the health condition		[78], [4]
Regulating Factor	IroA , , , ,
Detailed Description	The protein IroA of Escherichia coli CFT073 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.
Microbe Influence17	Sequestration of human SLC39A14 substrates/drugs in the health condition		[10], [79], [3], [4]
Regulating Factor	iroN
Detailed Description	The protein iroN of Escherichia coli O18:H7 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence18	Co-transport of human SLC39A14 substrates/drugs in the health condition		[15], [80], [18]
Regulating Factor	ZnuABC , ,
Detailed Description	The protein ZnuABC of Escherichia coli SB2847 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.
Microbe Influence19	Up regulating of SLC39A14 expression in the health condition		[18], [81]
Regulating Factor	Lipopolysaccharide
Studied Tissue	Liver
In Vivo Model	CD-1 mice
Detailed Description	The compound Lipopolysaccharide Generated by Escherichia coli O55 has been reported to increase the expression of the drug transporter SLC39A14.
Genus: Haemophilus
Haemophilus influenzae	Microbe Info	Click to Show/Hide the Full List 3 Microbe Influence Related to This Species
Microbe Influence1	Co-transport of human SLC39A14 substrates/drugs in the health condition		[10], [82], [4]
Regulating Factor	FhuCDB , ,
Detailed Description	The protein FhuCDB of Haemophilus influenzae R2866 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.
Microbe Influence2	Sequestration of human SLC39A14 substrates/drugs in the health condition		[3], [4], [6], [33], [83]
Regulating Factor	tbpA
Detailed Description	The protein tbpA of Haemophilus influenzae type b has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence3	Sequestration of human SLC39A14 substrates/drugs in the health condition		[3], [4], [6], [33], [83]
Regulating Factor	tbpB
Detailed Description	The protein tbpB of Haemophilus influenzae type b has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
[Haemophilus] ducreyi	Microbe Info	Click to Show/Hide the Full List 1 Microbe Influence Related to This Species
Microbe Influence1	Sequestration of human SLC39A14 substrates/drugs in the health condition		[15], [16], [18], [84]
Regulating Factor	znuA
Detailed Description	The protein znuA of [Haemophilus] ducreyi 35000HP has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Genus: Klebsiella
Klebsiella pneumoniae	Microbe Info	Click to Show/Hide the Full List 6 Microbe Influence Related to This Species
Microbe Influence1	Sequestration of human SLC39A14 substrates/drugs in pneumonia condition		[1], [85], [3], [4]
Regulating Factor	Yersiniabactin
Studied Phenotype	Pneumonia [ICD11: CA40]
Studied Tissue	Lung
In Vivo Model	C57BL/6 mice
Detailed Description	The compound Yersiniabactin Secreted by Klebsiella pneumoniae ATCC 43816 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence2	Sequestration of human SLC39A14 substrates/drugs in lung adenocarcinoma condition		[1], [86], [3], [4]
Regulating Factor	Salmochelin SX
Studied Phenotype	Lung cancer [ICD11: 2C25]
Studied Tissue	Lung
In Vitro Model	Human lung adenocarcinoma cells (A549)
Detailed Description	The compound Salmochelin SX Secreted by Klebsiella pneumoniae KP20 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence3	Sequestration of human SLC39A14 substrates/drugs in the health condition		[15], [87], [3], [4]
Regulating Factor	Salmochelin SX
Studied Tissue	Lung
In Vivo Model	C57BL/6 mice
Detailed Description	The compound Salmochelin SX Secreted by Klebsiella pneumoniae KPPR1 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence4	Sequestration of human SLC39A14 substrates/drugs in the health condition		[15], [87], [3], [4]
Regulating Factor	Yersiniabactin
Studied Tissue	Lung
In Vivo Model	C57BL/6 mice
Detailed Description	The compound Yersiniabactin Secreted by Klebsiella pneumoniae KPPR1 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence5	Sequestration of human SLC39A14 substrates/drugs in the health condition		[15], [88], [3], [4]
Regulating Factor	Enterobactin
Detailed Description	The compound Enterobactin Secreted by Klebsiella pneumoniae 298/53 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence6	Co-transport of human SLC39A14 substrates/drugs in the health condition		[54], [89], [4]
Regulating Factor	feoC
Detailed Description	The protein feoc of Klebsiella pneumoniae has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.
Genus: Moraxella
Moraxella catarrhalis	Microbe Info	Click to Show/Hide the Full List 4 Microbe Influence Related to This Species
Microbe Influence1	Sequestration of human SLC39A14 substrates/drugs in the health condition		[1], [90], [3], [4]
Regulating Factor	lbpA
Detailed Description	The protein lbpa of Moraxella catarrhalis has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence2	Sequestration of human SLC39A14 substrates/drugs in the health condition		[1], [90], [3], [4]
Regulating Factor	lbpB
Detailed Description	The protein lbpb of Moraxella catarrhalis has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence3	Sequestration of human SLC39A14 substrates/drugs in the health condition		[1], [90], [3], [4]
Regulating Factor	tbpA
Detailed Description	The protein tbpa of Moraxella catarrhalis has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence4	Sequestration of human SLC39A14 substrates/drugs in the health condition		[1], [90], [3], [4]
Regulating Factor	tbpB
Detailed Description	The protein tbpb of Moraxella catarrhalis has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Genus: Morganella
Morganella morganii	Microbe Info	Click to Show/Hide the Full List 5 Microbe Influence Related to This Species
Microbe Influence1	Sequestration of human SLC39A14 substrates/drugs in the health condition		[5], [91], [3], [4]
Regulating Factor	2-Oxoadipic acid
Detailed Description	The compound 2-Oxoadipic acid Secreted by Morganella morganii SBK3 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence2	Sequestration of human SLC39A14 substrates/drugs in the health condition		[5], [91], [3], [4]
Regulating Factor	3-Methyl-2-oxobutanoic acid
Detailed Description	The compound 3-Methyl-2-oxobutanoic acid Secreted by Morganella morganii SBK3 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence3	Sequestration of human SLC39A14 substrates/drugs in the health condition		[5], [91], [3], [4]
Regulating Factor	4-Methyl-2-oxopentanoic acid
Detailed Description	The compound 4-Methyl-2-oxopentanoic acid Secreted by Morganella morganii SBK3 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence4	Sequestration of human SLC39A14 substrates/drugs in the health condition		[5], [91], [3], [4]
Regulating Factor	Indole-3-pyruvic acid
Detailed Description	The compound Indole-3-pyruvic acid Secreted by Morganella morganii SBK3 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence5	Sequestration of human SLC39A14 substrates/drugs in the health condition		[5], [91], [3], [4]
Regulating Factor	Phenylpyruvic acid
Detailed Description	The compound Phenylpyruvic acid Secreted by Morganella morganii SBK3 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Genus: Neisseria
Neisseria gonorrhoeae	Microbe Info	Click to Show/Hide the Full List 3 Microbe Influence Related to This Species
Microbe Influence1	Sequestration of human SLC39A14 substrates/drugs in the health condition		[10], [92], [3], [4]
Regulating Factor	lbpA
Detailed Description	The protein lbpA of Neisseria gonorrhoeae FA19 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence2	Sequestration of human SLC39A14 substrates/drugs in the health condition		[3], [4], [6], [33], [83]
Regulating Factor	tbpA
Detailed Description	The protein tbpa of Neisseria gonorrhoeae has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence3	Sequestration of human SLC39A14 substrates/drugs in the health condition		[3], [4], [6], [33], [83]
Regulating Factor	tbpB
Detailed Description	The protein tbpb of Neisseria gonorrhoeae has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Neisseria meningitidis	Microbe Info	Click to Show/Hide the Full List 3 Microbe Influence Related to This Species
Microbe Influence1	Sequestration of human SLC39A14 substrates/drugs in bacterial meningitis condition		[15], [18], [93]
Regulating Factor	ZnuD
Studied Phenotype	Bacterial meningitis [ICD11: 1D01.0]
Studied Tissue	Brain
In Vivo Model	C57BL/6 mice
Detailed Description	The protein ZnuD of Neisseria meningitidis B16B6 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence2	Sequestration of human SLC39A14 substrates/drugs in the health condition		[3], [4], [6], [33], [83]
Regulating Factor	tbp1
Detailed Description	The protein tbp1 of Neisseria meningitidis has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence3	Sequestration of human SLC39A14 substrates/drugs in the health condition		[3], [4], [6], [33], [83]
Regulating Factor	tbpB
Detailed Description	The protein tbpb of Neisseria meningitidis has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Genus: Pasteurella
Pasteurella multocida	Microbe Info	Click to Show/Hide the Full List 1 Microbe Influence Related to This Species
Microbe Influence1	Co-transport of human SLC39A14 substrates/drugs in the health condition		[15], [18], [94]
Regulating Factor	ZnuABC , ,
Studied Tissue	Intestine
In Vivo Model	Swiss mice
Detailed Description	The protein ZnuABC of Pasteurella multocida PM25 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.
Genus: Proteus
Proteus mirabilis	Microbe Info	Click to Show/Hide the Full List 5 Microbe Influence Related to This Species
Microbe Influence1	Sequestration of human SLC39A14 substrates/drugs in the health condition		[5], [91], [3], [4]
Regulating Factor	2-Oxoadipic acid
Detailed Description	The compound 2-Oxoadipic acid Secreted by Proteus mirabilis NM 12 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence2	Sequestration of human SLC39A14 substrates/drugs in the health condition		[5], [91], [3], [4]
Regulating Factor	3-Methyl-2-oxobutanoic acid
Detailed Description	The compound 3-Methyl-2-oxobutanoic acid Secreted by Proteus mirabilis NM 12 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence3	Sequestration of human SLC39A14 substrates/drugs in the health condition		[5], [91], [3], [4]
Regulating Factor	4-Methyl-2-oxopentanoic acid
Detailed Description	The compound 4-Methyl-2-oxopentanoic acid Secreted by Proteus mirabilis NM 12 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence4	Sequestration of human SLC39A14 substrates/drugs in the health condition		[5], [91], [3], [4]
Regulating Factor	Indole-3-pyruvic acid
Detailed Description	The compound Indole-3-pyruvic acid Secreted by Proteus mirabilis NM 12 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence5	Sequestration of human SLC39A14 substrates/drugs in the health condition		[5], [91], [3], [4]
Regulating Factor	Phenylpyruvic acid
Detailed Description	The compound Phenylpyruvic acid Secreted by Proteus mirabilis NM 12 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Proteus penneri	Microbe Info	Click to Show/Hide the Full List 5 Microbe Influence Related to This Species
Microbe Influence1	Sequestration of human SLC39A14 substrates/drugs in the health condition		[5], [91], [3], [4]
Regulating Factor	2-Oxoadipic acid
Detailed Description	The compound 2-oxoadipic acid secreted by Proteus penneri has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence2	Sequestration of human SLC39A14 substrates/drugs in the health condition		[5], [91], [3], [4]
Regulating Factor	3-Methyl-2-oxobutanoic acid
Detailed Description	The compound 3-methyl-2-oxobutanoic acid secreted by Proteus penneri has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence3	Sequestration of human SLC39A14 substrates/drugs in the health condition		[5], [91], [3], [4]
Regulating Factor	4-Methyl-2-oxopentanoic acid
Detailed Description	The compound 4-methyl-2-oxopentanoic acid secreted by Proteus penneri has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence4	Sequestration of human SLC39A14 substrates/drugs in the health condition		[5], [91], [3], [4]
Regulating Factor	Indole-3-pyruvic acid
Detailed Description	The compound indole-3-pyruvic acid secreted by Proteus penneri has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence5	Sequestration of human SLC39A14 substrates/drugs in the health condition		[5], [91], [3], [4]
Regulating Factor	Phenylpyruvic acid
Detailed Description	The compound phenylpyruvic acid secreted by Proteus penneri has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Proteus vulgaris	Microbe Info	Click to Show/Hide the Full List 5 Microbe Influence Related to This Species
Microbe Influence1	Sequestration of human SLC39A14 substrates/drugs in the health condition		[5], [91], [3], [4]
Regulating Factor	2-Oxoadipic acid
Detailed Description	The compound 2-Oxoadipic acid Secreted by Proteus vulgaris Ox 19 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence2	Sequestration of human SLC39A14 substrates/drugs in the health condition		[5], [91], [3], [4]
Regulating Factor	3-Methyl-2-oxobutanoic acid
Detailed Description	The compound 3-Methyl-2-oxobutanoic acid Secreted by Proteus vulgaris Ox 19 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence3	Sequestration of human SLC39A14 substrates/drugs in the health condition		[5], [91], [3], [4]
Regulating Factor	4-Methyl-2-oxopentanoic acid
Detailed Description	The compound 4-Methyl-2-oxopentanoic acid Secreted by Proteus vulgaris Ox 19 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence4	Sequestration of human SLC39A14 substrates/drugs in the health condition		[5], [91], [3], [4]
Regulating Factor	Indole-3-pyruvic acid
Detailed Description	The compound Indole-3-pyruvic acid Secreted by Proteus vulgaris Ox 19 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence5	Sequestration of human SLC39A14 substrates/drugs in the health condition		[5], [91], [3], [4]
Regulating Factor	Phenylpyruvic acid
Detailed Description	The compound Phenylpyruvic acid Secreted by Proteus vulgaris Ox 19 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Genus: Providencia
Providencia alcalifaciens	Microbe Info	Click to Show/Hide the Full List 5 Microbe Influence Related to This Species
Microbe Influence1	Sequestration of human SLC39A14 substrates/drugs in the health condition		[5], [91], [3], [4]
Regulating Factor	2-Oxoadipic acid
Detailed Description	The compound 2-oxoadipic acid secreted by Providencia alcalifaciens 5487 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence2	Sequestration of human SLC39A14 substrates/drugs in the health condition		[5], [91], [3], [4]
Regulating Factor	3-Methyl-2-oxobutanoic acid
Detailed Description	The compound 3-methyl-2-oxobutanoic acid secreted by Providencia alcalifaciens 5487 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence3	Sequestration of human SLC39A14 substrates/drugs in the health condition		[5], [91], [3], [4]
Regulating Factor	4-Methyl-2-oxopentanoic acid
Detailed Description	The compound 4-methyl-2-oxopentanoic acid secreted by Providencia alcalifaciens 5487 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence4	Sequestration of human SLC39A14 substrates/drugs in the health condition		[5], [91], [3], [4]
Regulating Factor	Indole-3-pyruvic acid
Detailed Description	The compound indole-3-pyruvic acid secreted by Providencia alcalifaciens 5487 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence5	Sequestration of human SLC39A14 substrates/drugs in the health condition		[5], [91], [3], [4]
Regulating Factor	Phenylpyruvic acid
Detailed Description	The compound phenylpyruvic acid secreted by Providencia alcalifaciens 5487 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Providencia rustigianii	Microbe Info	Click to Show/Hide the Full List 5 Microbe Influence Related to This Species
Microbe Influence1	Sequestration of human SLC39A14 substrates/drugs in the health condition		[5], [91], [3], [4]
Regulating Factor	2-Oxoadipic acid
Detailed Description	The compound 2-oxoadipic acid secreted by Providencia rustigianii 2 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence2	Sequestration of human SLC39A14 substrates/drugs in the health condition		[5], [91], [3], [4]
Regulating Factor	3-Methyl-2-oxobutanoic acid
Detailed Description	The compound 3-methyl-2-oxobutanoic acid secreted by Providencia rustigianii 2 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence3	Sequestration of human SLC39A14 substrates/drugs in the health condition		[5], [91], [3], [4]
Regulating Factor	4-Methyl-2-oxopentanoic acid
Detailed Description	The compound 4-methyl-2-oxopentanoic acid secreted by Providencia rustigianii 2 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence4	Sequestration of human SLC39A14 substrates/drugs in the health condition		[5], [91], [3], [4]
Regulating Factor	Indole-3-pyruvic acid
Detailed Description	The compound indole-3-pyruvic acid secreted by Providencia rustigianii 2 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence5	Sequestration of human SLC39A14 substrates/drugs in the health condition		[5], [91], [3], [4]
Regulating Factor	Phenylpyruvic acid
Detailed Description	The compound phenylpyruvic acid secreted by Providencia rustigianii 2 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Providencia stuartii	Microbe Info	Click to Show/Hide the Full List 5 Microbe Influence Related to This Species
Microbe Influence1	Sequestration of human SLC39A14 substrates/drugs in the health condition		[5], [91], [3], [4]
Regulating Factor	2-Oxoadipic acid
Detailed Description	The compound 2-oxoadipic acid secreted by Providencia stuartii 19 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence2	Sequestration of human SLC39A14 substrates/drugs in the health condition		[5], [91], [3], [4]
Regulating Factor	3-Methyl-2-oxobutanoic acid
Detailed Description	The compound 3-methyl-2-oxobutanoic acid secreted by Providencia stuartii 19 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence3	Sequestration of human SLC39A14 substrates/drugs in the health condition		[5], [91], [3], [4]
Regulating Factor	4-Methyl-2-oxopentanoic acid
Detailed Description	The compound 4-methyl-2-oxopentanoic acid secreted by Providencia stuartii 19 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence4	Sequestration of human SLC39A14 substrates/drugs in the health condition		[5], [91], [3], [4]
Regulating Factor	Indole-3-pyruvic acid
Detailed Description	The compound indole-3-pyruvic acid secreted by Providencia stuartii 19 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence5	Sequestration of human SLC39A14 substrates/drugs in the health condition		[5], [91], [3], [4]
Regulating Factor	Phenylpyruvic acid
Detailed Description	The compound phenylpyruvic acid secreted by Providencia stuartii 19 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Genus: Pseudomonas
Pseudomonas aeruginosa	Microbe Info	Click to Show/Hide the Full List 6 Microbe Influence Related to This Species
Microbe Influence1	Sequestration of human SLC39A14 substrates/drugs in cystic fibrosis condition		[95], [3], [4]
Regulating Factor	Pyochelin
Studied Phenotype	Cystic fibrosis [ICD11: CA25]
Studied Tissue	Lung
In Vivo Model	CD-1 mice
Detailed Description	The compound Pyochelin Secreted by Pseudomonas aeruginosa ATCC 15692 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence2	Sequestration of human SLC39A14 substrates/drugs in cystic fibrosis condition		[95], [3], [4]
Regulating Factor	Pyoverdine F-Iib
Studied Phenotype	Cystic fibrosis [ICD11: CA25]
Studied Tissue	Lung
In Vivo Model	CD-1 mice
Detailed Description	The compound Pyoverdine F-Iib Secreted by Pseudomonas aeruginosa ATCC 15692 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence3	Sequestration of human SLC39A14 substrates/drugs in the health condition		[5], [96], [3], [4]
Regulating Factor	Pyochelin
Detailed Description	The compound Pyochelin Secreted by Pseudomonas aeruginosa PAO1 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence4	Sequestration of human SLC39A14 substrates/drugs in the health condition		[5], [97], [3], [4]
Regulating Factor	Pyoverdin
Detailed Description	The compound Pyoverdin Secreted by Pseudomonas aeruginosa PAO1 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence5	Sequestration of human SLC39A14 substrates/drugs in the health condition		[98], [3], [4]
Regulating Factor	tonB
Detailed Description	The protein tonB of Pseudomonas aeruginosa K199 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence6	Sequestration of human SLC39A14 substrates/drugs in the health condition		[99], [3], [4]
Regulating Factor	TonB1
Detailed Description	The protein TonB1 of Pseudomonas aeruginosa K1040 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Genus: Salmonella
Salmonella enterica	Microbe Info	Click to Show/Hide the Full List 17 Microbe Influence Related to This Species
Microbe Influence1	Sequestration of human SLC39A14 substrates/drugs in the health condition		[15], [100], [3], [4]
Regulating Factor	Enterobactin
Studied Tissue	Intestine
In Vivo Model	C3H/HeOuJ mice
Detailed Description	The compound Enterobactin Secreted by Salmonella enterica subsp. enterica serovar Typhimurium str. 14028S has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence2	Sequestration of human SLC39A14 substrates/drugs in the health condition		[15], [100], [3], [4]
Regulating Factor	Salmochelin SX
Studied Tissue	Intestine
In Vivo Model	C3H/HeOuJ mice
Detailed Description	The compound Salmochelin SX Secreted by Salmonella enterica subsp. enterica serovar Typhimurium str. 14028S has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence3	Sequestration of human SLC39A14 substrates/drugs in the health condition		[15], [101], [3], [4]
Regulating Factor	Enterobactin
Detailed Description	The compound Enterobactin Secreted by Salmonella enterica subsp. enterica serovar Typhimurium str. LT2 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence4	Sequestration of human SLC39A14 substrates/drugs in the health condition		[5], [102], [4]
Regulating Factor	Ferrioxamine B
Detailed Description	The compound Ferrioxamine B Secreted by Salmonella enterica subsp. enterica serovar Typhimurium str. ATCC 14028 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence5	Sequestration of human SLC39A14 substrates/drugs in the health condition		[5], [102], [4]
Regulating Factor	Ferrioxamine E
Detailed Description	The compound Ferrioxamine E Secreted by Salmonella enterica subsp. enterica serovar Typhimurium str. ATCC 14028 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence6	Sequestration of human SLC39A14 substrates/drugs in the health condition		[5], [102], [4]
Regulating Factor	Ferrioxamine G1
Detailed Description	The compound Ferrioxamine G1 Secreted by Salmonella enterica subsp. enterica serovar Typhimurium str. ATCC 14028 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence7	Sequestration of human SLC39A14 substrates/drugs in the health condition		[13], [103], [3], [4]
Regulating Factor	Salmochelin SX
Detailed Description	The compound Salmochelin SX Secreted by Salmonella enterica subsp. enterica serovar Typhimurium str. LT2 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence8	Sequestration of human SLC39A14 substrates/drugs in colon cancer condition		[15], [18], [104]
Regulating Factor	znuA
Studied Phenotype	Colon cancer [ICD11: 2B90]
Studied Tissue	Colon
In Vitro Model	Human colon adenocarcinoma cells (Caco-2)
Detailed Description	The protein znuA of Salmonella enterica subsp. enterica serovar Typhimurium str. ATCC 14028 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence9	Co-transport of human SLC39A14 substrates/drugs in the health condition		[15], [100], [3], [4]
Regulating Factor	fepD
Studied Tissue	Intestine
In Vivo Model	C3H/HeOuJ mice
Detailed Description	The protein fepD of Salmonella enterica subsp. enterica serovar Typhimurium str. 14028S has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.
Microbe Influence10	Co-transport of human SLC39A14 substrates/drugs in the health condition		[15], [18], [105]
Regulating Factor	ZnuABC , ,
Studied Tissue	Intestine
In Vivo Model	C57BL/6 mice
Detailed Description	The protein ZnuABC of Salmonella enterica subsp. enterica serovar Typhimurium IR715 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.
Microbe Influence11	Co-transport of human SLC39A14 substrates/drugs in the health condition		[15], [18], [106]
Regulating Factor	ZnuABC , ,
Studied Tissue	Blood
In Vivo Model	BALB/c mice
Detailed Description	The protein ZnuABC of Salmonella enterica subsp. enterica serovar Typhimurium str. ATCC 14028 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.
Microbe Influence12	Co-transport of human SLC39A14 substrates/drugs in the health condition		[54], [107], [4]
Regulating Factor	feoA
Detailed Description	The protein feoA of Salmonella enterica subsp. enterica serovar Typhimurium str. 14028S has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.
Microbe Influence13	Co-transport of human SLC39A14 substrates/drugs in the health condition		[10], [108], [4]
Regulating Factor	feoB
Detailed Description	The protein feoB of Salmonella enterica subsp. enterica serovar Typhimurium str. ATCC 14028 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.
Microbe Influence14	Sequestration of human SLC39A14 substrates/drugs in the health condition		[54], [107], [4]
Regulating Factor	feoB
Detailed Description	The protein feoB of Salmonella enterica subsp. enterica serovar Typhimurium str. 14028S has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence15	Co-transport of human SLC39A14 substrates/drugs in the health condition		[54], [107], [4]
Regulating Factor	feoC
Detailed Description	The protein feoC of Salmonella enterica subsp. enterica serovar Typhimurium str. 14028S has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.
Microbe Influence16	Co-transport of human SLC39A14 substrates/drugs in the health condition		[15], [100], [4]
Regulating Factor	SitABCD , , ,
Detailed Description	The protein SitABCD of Salmonella enterica subsp. enterica serovar Typhimurium JF2043 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.
Microbe Influence17	Co-transport of human SLC39A14 substrates/drugs in the health condition		[10], [108], [3], [4]
Regulating Factor	tonB
Detailed Description	The protein tonB of Salmonella enterica subsp. enterica serovar Typhimurium str. ATCC 14028 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.
Genus: Serratia
Serratia marcescens	Microbe Info	Click to Show/Hide the Full List 3 Microbe Influence Related to This Species
Microbe Influence1	Sequestration of human SLC39A14 substrates/drugs in the health condition		[54], [55], [109], [4]
Regulating Factor	sfuA
Detailed Description	The protein sfua of Serratia marcescens has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence2	Co-transport of human SLC39A14 substrates/drugs in the health condition		[54], [55], [109], [4]
Regulating Factor	sfuB
Detailed Description	The protein sfub of Serratia marcescens has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.
Microbe Influence3	Co-transport of human SLC39A14 substrates/drugs in the health condition		[54], [55], [109], [4]
Regulating Factor	sfuC
Detailed Description	The protein sfuc of Serratia marcescens has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.
Genus: Shigella
Shigella flexneri	Microbe Info	Click to Show/Hide the Full List 4 Microbe Influence Related to This Species
Microbe Influence1	Sequestration of human SLC39A14 substrates/drugs in the health condition		[10], [110], [4]
Regulating Factor	fec
Detailed Description	The protein fec of Shigella flexneri 2a has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence2	Co-transport of human SLC39A14 substrates/drugs in the health condition		[10], [111], [4]
Regulating Factor	feoB
Detailed Description	The protein feoB of Shigella flexneri SA100 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.
Microbe Influence3	Co-transport of human SLC39A14 substrates/drugs in the health condition		[10], [111], [4]
Regulating Factor	sitA
Detailed Description	The protein sitA of Shigella flexneri SA100 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.
Microbe Influence4	Co-transport of human SLC39A14 substrates/drugs in the health condition		[35], [36], [111], [4]
Regulating Factor	SitABCD , , ,
Detailed Description	The protein SitABCD of Shigella flexneri SA100 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.
Shigella sonnei	Microbe Info	Click to Show/Hide the Full List 1 Microbe Influence Related to This Species
Microbe Influence1	Sequestration of human SLC39A14 substrates/drugs in the health condition		[15], [88], [3], [4]
Regulating Factor	Enterobactin
Detailed Description	The compound Enterobactin Secreted by Shigella sonnei 43-GG9 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Genus: Vibrio
Vibrio anguillarum	Microbe Info	Click to Show/Hide the Full List 3 Microbe Influence Related to This Species
Microbe Influence1	Sequestration of human SLC39A14 substrates/drugs in the health condition		[5], [112], [3], [4]
Regulating Factor	Anguibactin
Detailed Description	The compound anguibactin secreted by Vibrio anguillarum 775 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence2	Co-transport of human SLC39A14 substrates/drugs in the health condition		[5], [112], [4]
Regulating Factor	fatA
Detailed Description	The protein fata of Vibrio anguillarum 775 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.
Microbe Influence3	Co-transport of human SLC39A14 substrates/drugs in the health condition		[5], [112], [4]
Regulating Factor	fatB
Detailed Description	The protein fatb of Vibrio anguillarum 775 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.
Vibrio cholerae	Microbe Info	Click to Show/Hide the Full List 6 Microbe Influence Related to This Species
Microbe Influence1	Sequestration of human SLC39A14 substrates/drugs in the health condition		[10], [113], [3], [4]
Regulating Factor	Vibriobactin
Detailed Description	The compound Vibriobactin Secreted by Vibrio cholerae Lou15 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence2	Sequestration of human SLC39A14 substrates/drugs in the health condition		[5], [114], [3], [4]
Regulating Factor	Vibriobactin
Detailed Description	The compound Vibriobactin Secreted by Vibrio cholerae MBG14 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence3	Co-transport of human SLC39A14 substrates/drugs in cholera condition		[15], [18], [115]
Regulating Factor	ZnuABC , ,
Studied Phenotype	Cholera [ICD11: 1A00]
Studied Tissue	Small intestine
In Vivo Model	CD-1 mice
Detailed Description	The protein ZnuABC of Vibrio cholerae C6706 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.
Microbe Influence4	Co-transport of human SLC39A14 substrates/drugs in cholera condition		[15], [18], [115]
Regulating Factor	ZrgABCDE , , , ,
Studied Phenotype	Cholera [ICD11: 1A00]
Studied Tissue	Small intestine
In Vivo Model	CD-1 mice
Detailed Description	The protein ZrgABCDE of Vibrio cholerae C6706 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.
Microbe Influence5	Co-transport of human SLC39A14 substrates/drugs in the health condition		[10], [116], [4]
Regulating Factor	Fbp
Detailed Description	The protein Fbp of Vibrio cholerae O395 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.
Microbe Influence6	Co-transport of human SLC39A14 substrates/drugs in the health condition		[10], [116], [4]
Regulating Factor	feo
Detailed Description	The protein feo of Vibrio cholerae O395 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.
Genus: Yersinia
Yersinia enterocolitica	Microbe Info	Click to Show/Hide the Full List 2 Microbe Influence Related to This Species
Microbe Influence1	Sequestration of human SLC39A14 substrates/drugs in the health condition		[5], [117], [3], [4]
Regulating Factor	Yersiniabactin
Detailed Description	The compound Yersiniabactin Secreted by Yersinia enterocolitica WA-C has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence2	Sequestration of human SLC39A14 substrates/drugs in the health condition		[5], [117], [4]
Regulating Factor	fyuA
Detailed Description	The protein fyuA of Yersinia enterocolitica WA-C has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Yersinia pestis	Microbe Info	Click to Show/Hide the Full List 8 Microbe Influence Related to This Species
Microbe Influence1	Sequestration of human SLC39A14 substrates/drugs in the health condition		[5], [118], [3], [4]
Regulating Factor	Yersiniabactin
Detailed Description	The compound Yersiniabactin Secreted by Yersinia pestis Yreka F1+VW+P1+P+ has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence2	Co-transport of human SLC39A14 substrates/drugs in septicemic plague condition		[15], [18], [119]
Regulating Factor	ZnuABC , ,
Studied Phenotype	Septicemic plague [ICD11: 1B93]
Studied Tissue	Blood
In Vivo Model	Swiss Webster mice
Detailed Description	The protein ZnuABC of Yersinia pestis KIM5 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.
Microbe Influence3	Co-transport of human SLC39A14 substrates/drugs in pneumonic plague condition		[120], [4]
Regulating Factor	feo
Studied Phenotype	Pneumonic plague [ICD11: 1B93.2]
Studied Tissue	Lung
In Vivo Model	Swiss Webster mice
Detailed Description	The protein feo of Yersinia pestis KIM6 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.
Microbe Influence4	Sequestration of human SLC39A14 substrates/drugs in the health condition		[10], [121], [3], [4]
Regulating Factor	irp2
Studied Tissue	Lung
In Vivo Model	Swiss Webster mice
Detailed Description	The protein irp2 of Yersinia pestis KIM5 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence5	Sequestration of human SLC39A14 substrates/drugs in the health condition		[10], [121], [4]
Regulating Factor	psn
Studied Tissue	Lung
In Vivo Model	Swiss Webster mice
Detailed Description	The protein psn of Yersinia pestis KIM5 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence6	Co-transport of human SLC39A14 substrates/drugs in the health condition		[10], [122], [4]
Regulating Factor	YfeAB ,
Studied Tissue	Blood
In Vivo Model	Swiss Webster mice
Detailed Description	The protein YfeAB of Yersinia pestis KIM5 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.
Microbe Influence7	Co-transport of human SLC39A14 substrates/drugs in the health condition		[120], [4]
Regulating Factor	YfeABCD , , ,
Studied Tissue	Lung
In Vivo Model	Swiss Webster mice
Detailed Description	The protein YfeABCD of Yersinia pestis KIM6 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.
Microbe Influence8	Co-transport of human SLC39A14 substrates/drugs in the health condition		[35], [36], [122], [4]
Regulating Factor	YfeABCD , , ,
Detailed Description	The protein YfeABCD of Yersinia pestis KIM5-2031.11+ has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.
Yersinia pseudotuberculosis	Microbe Info	Click to Show/Hide the Full List 1 Microbe Influence Related to This Species
Microbe Influence1	Sequestration of human SLC39A14 substrates/drugs in the health condition		[123], [4]
Regulating Factor	tssS
Detailed Description	The protein tssS of Yersinia pseudotuberculosis YPIII has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Bacteria: Spirochaetota
Genus: Treponema
Treponema pallidum	Microbe Info	Click to Show/Hide the Full List 3 Microbe Influence Related to This Species
Microbe Influence1	Sequestration of human SLC39A14 substrates/drugs in the health condition		[124], [4]
Regulating Factor	troA
Detailed Description	The protein troA of Treponema pallidum subsp. pallidum str. Nichols has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence2	Sequestration of human SLC39A14 substrates/drugs in the health condition		[124], [3], [4]
Regulating Factor	troA
Detailed Description	The protein troA of Treponema pallidum subsp. pallidum str. Nichols has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Microbe Influence3	Sequestration of human SLC39A14 substrates/drugs in the health condition		[15], [18], [124]
Regulating Factor	troA
Detailed Description	The protein troA of Treponema pallidum subsp. pallidum str. Nichols has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
Fungi: Ascomycota
Genus: Aspergillus
Aspergillus fumigatus	Microbe Info	Click to Show/Hide the Full List 3 Microbe Influence Related to This Species
Microbe Influence1	Co-transport of human SLC39A14 substrates/drugs in the health condition		[15], [18], [125], [126], [127]
Regulating Factor	zrfA
Detailed Description	The protein zrfA of Aspergillus fumigatus CETC has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.
Microbe Influence2	Co-transport of human SLC39A14 substrates/drugs in the health condition		[15], [18], [125], [126], [127]
Regulating Factor	zrfB
Detailed Description	The protein zrfB of Aspergillus fumigatus CETC has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.
Microbe Influence3	Co-transport of human SLC39A14 substrates/drugs in the health condition		[15], [18], [125], [126], [128]
Regulating Factor	zrfC
Detailed Description	The protein zrfC of Aspergillus fumigatus CEA17 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.
Genus: Candida
Candida albicans	Microbe Info	Click to Show/Hide the Full List 5 Microbe Influence Related to This Species
Microbe Influence1	Co-transport of human SLC39A14 substrates/drugs in the health condition		[15], [87], [3], [4]
Regulating Factor	Sit1p
Studied Tissue	Blood
In Vivo Model	BALB/c mice
Detailed Description	The protein Sit1p of Candida albicans CAF2-1 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.
Microbe Influence2	Co-transport of human SLC39A14 substrates/drugs in the health condition		[15], [129], [4]
Regulating Factor	CaFTR1
Detailed Description	The protein caftr1 of Candida albicans has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.
Microbe Influence3	Co-transport of human SLC39A14 substrates/drugs in the health condition		[15], [130], [18]
Regulating Factor	ZRT1
Detailed Description	The protein zrt1 of Candida albicans has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.
Microbe Influence4	Co-transport of human SLC39A14 substrates/drugs in the health condition		[15], [125], [131], [18]
Regulating Factor	ZRT1
Detailed Description	The protein ZRT1 of Candida albicans M134 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.
Microbe Influence5	Co-transport of human SLC39A14 substrates/drugs in the health condition		[15], [130], [18]
Regulating Factor	ZRT2
Detailed Description	The protein zrt2 of Candida albicans has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.
Fungi: Mucoromycota
Genus: Rhizopus
Rhizopus microsporus	Microbe Info	Click to Show/Hide the Full List 1 Microbe Influence Related to This Species
Microbe Influence1	Sequestration of human SLC39A14 substrates/drugs in the health condition		[1], [132], [3], [4]
Regulating Factor	Rhizoferrin
Detailed Description	The compound rhizoferrin secreted by Rhizopus microsporus has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

References
1	The commensal lifestyle of Staphylococcus aureus and its interactions with the nasal microbiota. Nat Rev Microbiol. 2017 Oct 12;15(11):675-687.
2	Purification and structural characterization of siderophore (corynebactin) from Corynebacterium diphtheriae. PLoS One. 2012;7(4):e34591.
3	Iron, copper, zinc, and manganese transport and regulation in pathogenic Enterobacteria: correlations between strains, site of infection and the relative importance of the different metal transport systems for virulence. Front Cell Infect Microbiol. 2013 Dec 5;3:90.
4	Iron and manganese transport in mammalian systems. Biochim Biophys Acta Mol Cell Res. 2021 Jan;1868(1):118890.
5	Iron metabolism in pathogenic bacteria. Annu Rev Microbiol. 2000;54:881-941.
6	Mycobacterium tuberculosis acquires iron by cell-surface sequestration and internalization of human holo-transferrin. Nat Commun. 2014 Aug 28;5:4730.
7	Exochelins of Mycobacterium tuberculosis remove iron from human iron-binding proteins and donate iron to mycobactins in the M. tuberculosis cell wall. J Exp Med. 1996 Apr 1;183(4):1527-32.
8	The Mycobacterium tuberculosis high-affinity iron importer, IrtA, contains an FAD-binding domain. J Bacteriol. 2010 Feb;192(3):861-9.
9	Iron uptake processes in Mycobacterium vaccae R877R, a mycobacterium lacking mycobactin. J Gen Microbiol. 1986 Mar;132(3):845-52.
10	Sequestration and scavenging of iron in infection. Infect Immun. 2013 Oct;81(10):3503-14.
11	IlsA, a unique surface protein of Bacillus cereus required for iron acquisition from heme, hemoglobin and ferritin. PLoS Pathog. 2009 Nov;5(11):e1000675.
12	Siderophores of Bacillus anthracis, Bacillus cereus, and Bacillus thuringiensis. Biochem Biophys Res Commun. 2006 Sep 15;348(1):320-5.
13	The battle for iron between bacterial pathogens and their vertebrate hosts. PLoS Pathog. 2010 Aug 12;6(8):e1000949.
14	Anthrax pathogen evades the mammalian immune system through stealth siderophore production. Proc Natl Acad Sci U S A. 2006 Dec 5;103(49):18499-503.
15	Transition metal ions at the crossroads of mucosal immunity and microbial pathogenesis. Front Cell Infect Microbiol. 2014 Jan 24;4:2.
16	A new family of high-affinity ABC manganese and zinc permeases. Res Microbiol. 2001 Apr-May;152(3-4):231-43.
17	Identification of a zinc-specific metalloregulatory protein, Zur, controlling zinc transport operons in Bacillus subtilis. J Bacteriol. 1998 Nov;180(22):5815-21.
18	Transition metals and host-microbe interactions in the inflamed intestine. Biometals. 2019 Jun;32(3):369-384.
19	Metallobiology of Lactobacillaceae in the gut microbiome. J Inorg Biochem. 2023 Jan;238:112023.
20	The complete genome sequence of the lactic acid bacterium Lactococcus lactis ssp. lactis IL1403. Genome Res. 2001 May;11(5):731-53.
21	Two zinc uptake systems contribute to the full virulence of Listeria monocytogenes during growth in vitro and in vivo. Infect Immun. 2012 Jan;80(1):14-21.
22	Siderophore production by Staphylococcus aureus and identification of iron-regulated proteins. Infect Immun. 1997 May;65(5):1944-8.
23	Identification and characterization of the Staphylococcus aureus gene cluster coding for staphyloferrin A. Biochemistry. 2009 Feb 10;48(5):1025-35.
24	Biosynthesis of a broad-spectrum nicotianamine-like metallophore in Staphylococcus aureus. Science. 2016 May 27;352(6289):1105-9.
25	Competitors versus Collaborators: Micronutrient Processing by Pathogenic and Commensal Human-Associated Gut Bacteria. Mol Cell. 2020 May 21;78(4):570-576.
26	Bacterial Strategies to Maintain Zinc Metallostasis at the Host-Pathogen Interface. J Biol Chem. 2016 Sep 30;291(40):20858-20868.
27	A metal-ligand-mediated intersubunit allosteric switch in related SmtB/ArsR zinc sensor proteins. J Mol Biol. 2003 Oct 31;333(4):683-95.
28	Siderophore-mediated iron acquisition in the staphylococci. J Inorg Biochem. 2010 Mar;104(3):282-8.
29	FhuD1, a ferric hydroxamate-binding lipoprotein in Staphylococcus aureus: a case of gene duplication and lateral transfer. J Biol Chem. 2004 Dec 17;279(51):53152-9.
30	The role of FhuD2 in iron(III)-hydroxamate transport in Staphylococcus aureus. Demonstration that FhuD2 binds iron(III)-hydroxamates but with minimal conformational change and implication of mutations on transport. J Biol Chem. 2003 Dec 12;278(50):49890-900.
31	Characterization of staphyloferrin A biosynthetic and transport mutants in Staphylococcus aureus. Mol Microbiol. 2009 May;72(4):947-63.
32	Transferrin binding in Staphylococcus aureus: involvement of a cell wall-anchored protein. Mol Microbiol. 2002 Mar;43(6):1603-14.
33	The staphylococcal transferrin-binding protein is a cell wall glyceraldehyde-3-phosphate dehydrogenase. Infect Immun. 1999 Mar;67(3):1086-92.
34	Staphylococci express a receptor for human transferrin: identification of a 42-kilodalton cell wall transferrin-binding protein. Infect Immun. 1994 Sep;62(9):3850-8.
35	Manganese homeostasis and utilization in pathogenic bacteria. Mol Microbiol. 2015 Jul;97(2):216-28.
36	Manganese transport and the role of manganese in virulence. Annu Rev Microbiol. 2006;60:187-209.
37	MntR modulates expression of the PerR regulon and superoxide resistance in Staphylococcus aureus through control of manganese uptake. Mol Microbiol. 2002 Jun;44(5):1269-86.
38	Involvement of SirABC in iron-siderophore import in Staphylococcus aureus. J Bacteriol. 2004 Dec;186(24):8356-62.
39	Molecular cloning and analysis of a putative siderophore ABC transporter from Staphylococcus aureus. Infect Immun. 2000 Nov;68(11):6281-8.
40	Evidence for siderophore-dependent iron acquisition in group B streptococcus. Mol Microbiol. 2006 Jan;59(2):707-21.
41	Identification of lipoprotein homologues of pneumococcal PsaA in the equine pathogens Streptococcus equi and Streptococcus zooepidemicus. Infect Immun. 2000 Oct;68(10):6048-51.
42	Involvement of the adc operon and manganese homeostasis in Streptococcus gordonii biofilm formation. J Bacteriol. 2003 May;185(9):2887-900.
43	Competence and virulence of Streptococcus pneumoniae: Adc and PsaA mutants exhibit a requirement for Zn and Mn resulting from inactivation of putative ABC metal permeases. Mol Microbiol. 1997 Aug;25(4):727-39.
44	TroA of Streptococcus suis is required for manganese acquisition and full virulence. J Bacteriol. 2011 Oct;193(19):5073-80.
45	Metal homeostasis in pathogenic Epsilonproteobacteria: mechanisms of acquisition, efflux, and regulation. Metallomics. 2021 Jan 16;13(1):mfaa002.
46	Nutrient acquisition and metabolism by Campylobacter jejuni. Front Cell Infect Microbiol. 2012 Feb 7;2:5.
47	Identification and characterization of a new ferric enterobactin receptor, CfrB, in Campylobacter. J Bacteriol. 2010 Sep;192(17):4425-35.
48	A Campylobacter jejuni znuA orthologue is essential for growth in low-zinc environments and chick colonization. J Bacteriol. 2009 Mar;191(5):1631-40.
49	Zinc competition among the intestinal microbiota. mBio. 2012 Jul 31;3(4):e00171-12.
50	Iron acquisition and regulation in Campylobacter jejuni. J Bacteriol. 2004 Jul;186(14):4714-29.
51	Utilization of lactoferrin-bound and transferrin-bound iron by Campylobacter jejuni. J Bacteriol. 2008 Mar;190(6):1900-11.
52	Major role for FeoB in Campylobacter jejuni ferrous iron acquisition, gut colonization, and intracellular survival. Infect Immun. 2006 Oct;74(10):5433-44.
53	Structure and function of P19, a high-affinity iron transporter of the human pathogen Campylobacter jejuni. J Mol Biol. 2010 Aug 27;401(4):590-604.
54	Bacterial ferrous iron transport: the Feo system. FEMS Microbiol Rev. 2016 Mar;40(2):273-98.
55	Iron-binding activity of FutA1 subunit of an ABC-type iron transporter in the cyanobacterium Synechocystis sp. Strain PCC 6803. Plant Cell Physiol. 2001 Aug;42(8):823-7.
56	Genes essential to iron transport in the cyanobacterium Synechocystis sp. strain PCC 6803. J Bacteriol. 2001 May;183(9):2779-84.
57	Contribution of Active Iron Uptake to Acinetobacter baumannii Pathogenicity. Infect Immun. 2019 Mar 25;87(4):e00755-18.
58	Identification of an Acinetobacter baumannii zinc acquisition system that facilitates resistance to calprotectin-mediated zinc sequestration. PLoS Pathog. 2012;8(12):e1003068.
59	Purification, spectroscopic analysis and biological activity of the macrocyclic dihydroxamate siderophore alcaligin produced by Bordetella pertussis and Bordetella bronchiseptica. Biometals. 1996 Apr;9(2):191-203.
60	Bacterial outer membrane channel for divalent metal ion acquisition. Proc Natl Acad Sci U S A. 2011 Sep 13;108(37):15390-5.
61	Zinc uptake system (znuA locus) of Brucella abortus is essential for intracellular survival and virulence in mice. J Vet Med Sci. 2004 Sep;66(9):1059-63.
62	Cepabactin from Pseudomonas cepacia, a new type of siderophore. J Gen Microbiol. 1989 Jun;135(6):1479-87.
63	Ornibactins--a new family of siderophores from Pseudomonas. Biometals. 1993 Summer;6(2):93-100.
64	Isolation of a novel siderophore from Pseudomonas cepacia. J Med Microbiol. 1992 Mar;36(3):184-9.
65	Relative availability of transferrin-bound iron and cell-derived iron to aerobactin-producing and enterochelin-producing strains of Escherichia coli and to other microorganisms. Infect Immun. 1991 Sep;59(9):3185-90.
66	The alternative role of enterobactin as an oxidative stress protector allows Escherichia coli colony development. PLoS One. 2014 Jan 2;9(1):e84734.
67	Production of enterochelin by Escherichia coli 0111. Biochim Biophys Acta. 1977 Apr 27;497(2):548-57.
68	The structure of enterochelin and related 2,3-dihydroxy-N-benzoylserine conjugates from Escherichia coli. Biochim Biophys Acta. 1970 Aug 14;215(2):393-402.
69	A new ferrous iron-uptake transporter, EfeU (YcdN), from Escherichia coli. Mol Microbiol. 2006 Oct;62(1):120-31.
70	EfeUOB (YcdNOB) is a tripartite, acid-induced and CpxAR-regulated, low-pH Fe2+ transporter that is cryptic in Escherichia coli K-12 but functional in E. coli O157:H7. Mol Microbiol. 2007 Aug;65(4):857-75.
71	Structural basis of gating by the outer membrane transporter FecA. Science. 2002 Mar 1;295(5560):1715-9.
72	Characterization of the ferrous iron uptake system of Escherichia coli. J Bacteriol. 1993 Oct;175(19):6212-9.
73	Iron uptake mechanisms and their regulation in pathogenic bacteria. Int J Med Microbiol. 2001 May;291(2):67-79.
74	Siderophore-mediated iron transport: crystal structure of FhuA with bound lipopolysaccharide. Science. 1998 Dec 18;282(5397):2215-20.
75	Transmembrane topology of the two FhuB domains representing the hydrophobic components of bacterial ABC transporters involved in the uptake of siderophores, haem and vitamin B12. Microbiology (Reading). 1998 Oct;144 ( Pt 10):2759-2769.
76	Iron(III) hydroxamate transport in Escherichia coli K-12: FhuB-mediated membrane association of the FhuC protein and negative complementation of fhuC mutants. J Bacteriol. 1992 Apr;174(7):2305-11.
77	The structure of the ferric siderophore binding protein FhuD complexed with gallichrome. Nat Struct Biol. 2000 Apr;7(4):287-91.
78	The pathogen-associated iroA gene cluster mediates bacterial evasion of lipocalin 2. Proc Natl Acad Sci U S A. 2006 Oct 31;103(44):16502-7.
79	The siderophore receptor IroN, but not the high-pathogenicity island or the hemin receptor ChuA, contributes to the bacteremic step of Escherichia coli neonatal meningitis. Infect Immun. 2004 Feb;72(2):1216-20.
80	The ZnuABC high-affinity zinc uptake system and its regulator Zur in Escherichia coli. Mol Microbiol. 1998 Jun;28(6):1199-210.
81	Interleukin-6 regulates the zinc transporter Zip14 in liver and contributes to the hypozincemia of the acute-phase response. Proc Natl Acad Sci U S A. 2005 May 10;102(19):6843-8.
82	Identification of a siderophore utilization locus in nontypeable Haemophilus influenzae. BMC Microbiol. 2010 Apr 15;10:113.
83	Iron piracy: acquisition of transferrin-bound iron by bacterial pathogens. Mol Microbiol. 1994 Dec;14(5):843-50.
84	Identification of the znuA-encoded periplasmic zinc transport protein of Haemophilus ducreyi. Infect Immun. 1999 Oct;67(10):5060-8.
85	Klebsiella pneumoniae yersiniabactin promotes respiratory tract infection through evasion of lipocalin 2. Infect Immun. 2011 Aug;79(8):3309-16.
86	Bacterial siderophores that evade or overwhelm lipocalin 2 induce hypoxia inducible factor 1alpha and proinflammatory cytokine secretion in cultured respiratory epithelial cells. Infect Immun. 2014 Sep;82(9):3826-36.
87	The siderophore iron transporter of Candida albicans (Sit1p/Arn1p) mediates uptake of ferrichrome-type siderophores and is required for epithelial invasion. Infect Immun. 2002 Sep;70(9):5246-55.
88	Siderophore synthesis in Klebsiella pneumoniae and Shigella sonnei during iron deficiency. J Bacteriol. 1979 Dec;140(3):1129-32.
89	NMR structure note: the ferrous iron transport protein C (FeoC) from Klebsiella pneumoniae. J Biomol NMR. 2012 Jun;53(2):161-5.
90	Moraxella catarrhalis: a review of an important human mucosal pathogen. Microbes Infect. 2000 Apr;2(5):547-59.
91	Alpha-keto acids are novel siderophores in the genera Proteus, Providencia, and Morganella and are produced by amino acid deaminases. J Bacteriol. 1993 May;175(9):2727-33.
92	Characterization of lbpA, the structural gene for a lactoferrin receptor in Neisseria gonorrhoeae. Infect Immun. 1995 Aug;63(8):2958-67.
93	The molecular mechanism of Zinc acquisition by the neisserial outer-membrane transporter ZnuD. Nat Commun. 2015 Aug 18;6:7996.
94	The high-affinity zinc-uptake system znuACB is under control of the iron-uptake regulator (fur) gene in the animal pathogen Pasteurella multocida. FEMS Microbiol Lett. 2003 Apr 11;221(1):31-7.
95	Role of Iron Uptake Systems in Pseudomonas aeruginosa Virulence and Airway Infection. Infect Immun. 2016 Jul 21;84(8):2324-2335.
96	Pyochelin: novel structure of an iron-chelating growth promoter for Pseudomonas aeruginosa. Proc Natl Acad Sci U S A. 1981 Jul;78(7):4256-60.
97	Effects of siderophores on the growth of Pseudomonas aeruginosa in human serum and transferrin. Infect Immun. 1985 Jul;49(1):132-40.
98	The Pseudomonas aeruginosa tonB gene encodes a novel TonB protein. Microbiology (Reading). 1996 Jun;142 ( Pt 6):1449-1458.
99	Mutational analysis of the TonB1 energy coupler of Pseudomonas aeruginosa. J Bacteriol. 2002 Mar;184(6):1503-13.
100	Biosynthesis and IroC-dependent export of the siderophore salmochelin are essential for virulence of Salmonella enterica serovar Typhimurium. Mol Microbiol. 2008 Mar;67(5):971-83.
101	Enterobactin, an iron transport compound from Salmonella typhimurium. Biochem Biophys Res Commun. 1970 Mar 12;38(5):989-92.
102	Ferrioxamine-mediated Iron(III) utilization by Salmonella enterica. Appl Environ Microbiol. 1999 Apr;65(4):1610-8.
103	Salmochelins, siderophores of Salmonella enterica and uropathogenic Escherichia coli strains, are recognized by the outer membrane receptor IroN. Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):3677-82.
104	Salmonella enterica serovar Typhimurium growth is inhibited by the concomitant binding of Zn(II) and a pyrrolyl-hydroxamate to ZnuA, the soluble component of the ZnuABC transporter. Biochim Biophys Acta. 2016 Mar;1860(3):534-41.
105	The cytokine IL-22 promotes pathogen colonization by suppressing related commensal bacteria. Immunity. 2014 Feb 20;40(2):262-73.
106	Role of the high-affinity zinc uptake znuABC system in Salmonella enterica serovar typhimurium virulence. Infect Immun. 2002 Aug;70(8):4721-5.
107	Lon-mediated proteolysis of the FeoC protein prevents Salmonella enterica from accumulating the Fe(II) transporter FeoB under high-oxygen conditions. J Bacteriol. 2015 Jan 1;197(1):92-8.
108	Contribution of TonB- and Feo-mediated iron uptake to growth of Salmonella typhimurium in the mouse. Infect Immun. 1996 Nov;64(11):4549-56.
109	Nucleotide sequences of the sfuA, sfuB, and sfuC genes of Serratia marcescens suggest a periplasmic-binding-protein-dependent iron transport mechanism. J Bacteriol. 1990 Feb;172(2):572-8.
110	Ferric dicitrate transport system (Fec) of Shigella flexneri 2a YSH6000 is encoded on a novel pathogenicity island carrying multiple antibiotic resistance genes. Infect Immun. 2001 Oct;69(10):6012-21.
111	Contribution of the Shigella flexneri Sit, Iuc, and Feo iron acquisition systems to iron acquisition in vitro and in cultured cells. Infect Immun. 2003 Apr;71(4):1919-28.
112	The AngR protein and the siderophore anguibactin positively regulate the expression of iron-transport genes in Vibrio anguillarum. Mol Microbiol. 1996 Oct;22(1):127-34.
113	Cloning of a Vibrio cholerae vibriobactin gene cluster: identification of genes required for early steps in siderophore biosynthesis. J Bacteriol. 1997 Nov;179(22):7055-62.
114	Cloning, sequencing, and transcriptional regulation of viuA, the gene encoding the ferric vibriobactin receptor of Vibrio cholerae. J Bacteriol. 1992 Jun;174(11):3729-38.
115	Dual Zinc Transporter Systems in Vibrio cholerae Promote Competitive Advantages over Gut Microbiome. Infect Immun. 2015 Oct;83(10):3902-8.
116	Characterization of ferric and ferrous iron transport systems in Vibrio cholerae. J Bacteriol. 2006 Sep;188(18):6515-23.
117	Purification of yersiniabactin: a siderophore and possible virulence factor of Yersinia enterocolitica. J Gen Microbiol. 1993 Sep;139(9):2159-65.
118	Siderochrome production by Yersinia pestis and its relation to virulence. Infect Immun. 1975 Nov;12(5):1211-3.
119	The Yersinia pestis siderophore, yersiniabactin, and the ZnuABC system both contribute to zinc acquisition and the development of lethal septicaemic plague in mice. Mol Microbiol. 2014 Aug;93(4):759-75.
120	The Yfe and Feo transporters are involved in microaerobic growth and virulence of Yersinia pestis in bubonic plague. Infect Immun. 2012 Nov;80(11):3880-91.
121	The yersiniabactin transport system is critical for the pathogenesis of bubonic and pneumonic plague. Infect Immun. 2010 May;78(5):2045-52.
122	The Yfe system of Yersinia pestis transports iron and manganese and is required for full virulence of plague. Mol Microbiol. 1999 Apr;32(2):403-14.
123	T6SS translocates a micropeptide to suppress STING-mediated innate immunity by sequestering manganese. Proc Natl Acad Sci U S A. 2021 Oct 19;118(42):e2103526118.
124	The general transition metal (Tro) and Zn2+ (Znu) transporters in Treponema pallidum: analysis of metal specificities and expression profiles. Mol Microbiol. 2007 Jul;65(1):137-52.
125	Immunological orchestration of zinc homeostasis: The battle between host mechanisms and pathogen defenses. Arch Biochem Biophys. 2016 Dec 1;611:66-78.
126	Zinc and Manganese Chelation by Neutrophil S100A8/A9 (Calprotectin) Limits Extracellular Aspergillus fumigatus Hyphal Growth and Corneal Infection. J Immunol. 2016 Jan 1;196(1):336-44.
127	The zrfA and zrfB genes of Aspergillus fumigatus encode the zinc transporter proteins of a zinc uptake system induced in an acid, zinc-depleted environment. Eukaryot Cell. 2005 May;4(5):837-48.
128	Aspergillus fumigatus survival in alkaline and extreme zinc-limiting environments relies on the induction of a zinc homeostasis system encoded by the zrfC and aspf2 genes. Eukaryot Cell. 2010 Mar;9(3):424-37.
129	A high-affinity iron permease essential for Candida albicans virulence. Science. 2000 May 12;288(5468):1062-4.
130	Zinc sequestration: arming phagocyte defense against fungal attack. PLoS Pathog. 2013;9(12):e1003815.
131	Candida albicans scavenges host zinc via Pra1 during endothelial invasion. PLoS Pathog. 2012;8(6):e1002777.
132	Rhizoferrin: a complexone type siderophore of the Mucorales and entomophthorales (Zygomycetes). FEMS Microbiol Lett. 1992 Jul 1;73(1-2):37-41.

If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.

Detail Information of Microbiota Influence

Visitor Map

Correspondence